Cargando…
The reproducibility of late gadolinium enhancement cardiovascular magnetic resonance imaging of post-ablation atrial scar: a cross-over study
BACKGROUND: Cardiovascular magnetic resonance (CMR) imaging has been used to visualise post-ablation atrial scar (PAAS), generally employing a three-dimensional (3D) late gadolinium enhancement (LGE) technique. However the reproducibility of PAAS imaging has not been determined. This cross-over stud...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858144/ https://www.ncbi.nlm.nih.gov/pubmed/29554919 http://dx.doi.org/10.1186/s12968-018-0438-y |
_version_ | 1783307599219785728 |
---|---|
author | Chubb, Henry Karim, Rashed Roujol, Sébastien Nuñez-Garcia, Marta Williams, Steven E. Whitaker, John Harrison, James Butakoff, Constantine Camara, Oscar Chiribiri, Amedeo Schaeffter, Tobias Wright, Matthew O’Neill, Mark Razavi, Reza |
author_facet | Chubb, Henry Karim, Rashed Roujol, Sébastien Nuñez-Garcia, Marta Williams, Steven E. Whitaker, John Harrison, James Butakoff, Constantine Camara, Oscar Chiribiri, Amedeo Schaeffter, Tobias Wright, Matthew O’Neill, Mark Razavi, Reza |
author_sort | Chubb, Henry |
collection | PubMed |
description | BACKGROUND: Cardiovascular magnetic resonance (CMR) imaging has been used to visualise post-ablation atrial scar (PAAS), generally employing a three-dimensional (3D) late gadolinium enhancement (LGE) technique. However the reproducibility of PAAS imaging has not been determined. This cross-over study is the first to investigate the reproducibility of the technique, crucial for both future research design and clinical implementation. METHODS: Forty subjects undergoing first time ablation for atrial fibrillation (AF) had detailed CMR assessment of PAAS. Following baseline pre-ablation scan, two scans (separated by 48 h) were performed at three months post-ablation. Each scan session included 3D LGE acquisition at 10, 20 and 30 min post administration of gadolinium-based contrast agent (GBCA). Subjects were allocated at second scan post-ablation to identical imaging parameters (‘Repro’, n = 10), 3 T scanner (‘3 T’, n = 10), half-slice thickness (‘Half-slice’, n = 10) or half GBCA dose (‘Half-gad’, n = 10). PAAS was compared to baseline scar and then reproducibility was assessed for two measures of thresholded scar (% left atrial (LA) occupied by PAAS (%LA PAAS) and Pulmonary Vein Encirclement (PVE)), and then four measures of non-thresholded scar (point-by-point assessment of PAAS, four normalisation methods). Thresholded measures of PAAS were evaluated against procedural outcome (AF recurrence). RESULTS: A total of 271 3D acquisitions (out of maximum 280, 96.7%) were acquired. At 20 and 30 min, inter-scan reproducibility was good to excellent (coefficient of variation at 20 min and 30 min: %LA PAAS 0.41 and 0.20; PVE 0.13 and 0.04 respectively for ‘Repro’ group). Changes in imaging parameters, especially reduced GBCA dose, reduced inter-scan reproducibility, but for most measures remained good to excellent (ICC for %LA PAAS 0.454–0.825, PVE 0.618–0.809 at 30 min). For non-thresholded scar, highest reproducibility was observed using blood pool z-score normalisation technique: inter-scan ICC 0.759 (absolute agreement, ‘Repro’ group). There was no significant relationship between indices of PAAS and AF recurrence. CONCLUSION: PAAS imaging is a reproducible finding. Imaging should be performed at least 20 min post-GBCA injection, and a blood pool z-score should be considered for normalisation of signal intensities. The clinical implications of these findings remain to be established in the absence of a simple correlation with arrhythmia outcome. TRIAL REGISTRATION: United Kingdom National Research Ethics Service 08/H0802/68 – 30th September 2008. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12968-018-0438-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5858144 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-58581442018-03-20 The reproducibility of late gadolinium enhancement cardiovascular magnetic resonance imaging of post-ablation atrial scar: a cross-over study Chubb, Henry Karim, Rashed Roujol, Sébastien Nuñez-Garcia, Marta Williams, Steven E. Whitaker, John Harrison, James Butakoff, Constantine Camara, Oscar Chiribiri, Amedeo Schaeffter, Tobias Wright, Matthew O’Neill, Mark Razavi, Reza J Cardiovasc Magn Reson Research BACKGROUND: Cardiovascular magnetic resonance (CMR) imaging has been used to visualise post-ablation atrial scar (PAAS), generally employing a three-dimensional (3D) late gadolinium enhancement (LGE) technique. However the reproducibility of PAAS imaging has not been determined. This cross-over study is the first to investigate the reproducibility of the technique, crucial for both future research design and clinical implementation. METHODS: Forty subjects undergoing first time ablation for atrial fibrillation (AF) had detailed CMR assessment of PAAS. Following baseline pre-ablation scan, two scans (separated by 48 h) were performed at three months post-ablation. Each scan session included 3D LGE acquisition at 10, 20 and 30 min post administration of gadolinium-based contrast agent (GBCA). Subjects were allocated at second scan post-ablation to identical imaging parameters (‘Repro’, n = 10), 3 T scanner (‘3 T’, n = 10), half-slice thickness (‘Half-slice’, n = 10) or half GBCA dose (‘Half-gad’, n = 10). PAAS was compared to baseline scar and then reproducibility was assessed for two measures of thresholded scar (% left atrial (LA) occupied by PAAS (%LA PAAS) and Pulmonary Vein Encirclement (PVE)), and then four measures of non-thresholded scar (point-by-point assessment of PAAS, four normalisation methods). Thresholded measures of PAAS were evaluated against procedural outcome (AF recurrence). RESULTS: A total of 271 3D acquisitions (out of maximum 280, 96.7%) were acquired. At 20 and 30 min, inter-scan reproducibility was good to excellent (coefficient of variation at 20 min and 30 min: %LA PAAS 0.41 and 0.20; PVE 0.13 and 0.04 respectively for ‘Repro’ group). Changes in imaging parameters, especially reduced GBCA dose, reduced inter-scan reproducibility, but for most measures remained good to excellent (ICC for %LA PAAS 0.454–0.825, PVE 0.618–0.809 at 30 min). For non-thresholded scar, highest reproducibility was observed using blood pool z-score normalisation technique: inter-scan ICC 0.759 (absolute agreement, ‘Repro’ group). There was no significant relationship between indices of PAAS and AF recurrence. CONCLUSION: PAAS imaging is a reproducible finding. Imaging should be performed at least 20 min post-GBCA injection, and a blood pool z-score should be considered for normalisation of signal intensities. The clinical implications of these findings remain to be established in the absence of a simple correlation with arrhythmia outcome. TRIAL REGISTRATION: United Kingdom National Research Ethics Service 08/H0802/68 – 30th September 2008. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12968-018-0438-y) contains supplementary material, which is available to authorized users. BioMed Central 2018-03-19 /pmc/articles/PMC5858144/ /pubmed/29554919 http://dx.doi.org/10.1186/s12968-018-0438-y Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Chubb, Henry Karim, Rashed Roujol, Sébastien Nuñez-Garcia, Marta Williams, Steven E. Whitaker, John Harrison, James Butakoff, Constantine Camara, Oscar Chiribiri, Amedeo Schaeffter, Tobias Wright, Matthew O’Neill, Mark Razavi, Reza The reproducibility of late gadolinium enhancement cardiovascular magnetic resonance imaging of post-ablation atrial scar: a cross-over study |
title | The reproducibility of late gadolinium enhancement cardiovascular magnetic resonance imaging of post-ablation atrial scar: a cross-over study |
title_full | The reproducibility of late gadolinium enhancement cardiovascular magnetic resonance imaging of post-ablation atrial scar: a cross-over study |
title_fullStr | The reproducibility of late gadolinium enhancement cardiovascular magnetic resonance imaging of post-ablation atrial scar: a cross-over study |
title_full_unstemmed | The reproducibility of late gadolinium enhancement cardiovascular magnetic resonance imaging of post-ablation atrial scar: a cross-over study |
title_short | The reproducibility of late gadolinium enhancement cardiovascular magnetic resonance imaging of post-ablation atrial scar: a cross-over study |
title_sort | reproducibility of late gadolinium enhancement cardiovascular magnetic resonance imaging of post-ablation atrial scar: a cross-over study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858144/ https://www.ncbi.nlm.nih.gov/pubmed/29554919 http://dx.doi.org/10.1186/s12968-018-0438-y |
work_keys_str_mv | AT chubbhenry thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy AT karimrashed thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy AT roujolsebastien thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy AT nunezgarciamarta thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy AT williamsstevene thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy AT whitakerjohn thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy AT harrisonjames thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy AT butakoffconstantine thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy AT camaraoscar thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy AT chiribiriamedeo thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy AT schaefftertobias thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy AT wrightmatthew thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy AT oneillmark thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy AT razavireza thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy AT chubbhenry reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy AT karimrashed reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy AT roujolsebastien reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy AT nunezgarciamarta reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy AT williamsstevene reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy AT whitakerjohn reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy AT harrisonjames reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy AT butakoffconstantine reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy AT camaraoscar reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy AT chiribiriamedeo reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy AT schaefftertobias reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy AT wrightmatthew reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy AT oneillmark reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy AT razavireza reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy |